KRAS and pancreatitis: We initially crossed Kras+/LSLG12D mice with Elas-CreER transgenic mice, and confirmed that expression of KrasG12D mutant in adult acinar cells was not sufficient to induce pancreatic tumorigenesis (Figure 1A–1B) unless mice were treated with cerulein, an experimental pancreatitis inducer (Figure 1C).